Dallin Dressman Has Been Accepted to the TRANSFORM TL1 Training Program
Dallin Dressman has been accepted to the TRANSFORM TL1 Training Program at the Columbia University Irving Institute for Clinical and Translational Research. Dallin Dressman is a PhD candidate in the Department of Molecular Pharmacology and Therapeutics graduate program. He is part of Dr. Wassim Elyaman's laboratory. Dallin is currently studying the role of T cells in Alzheimer's disease, and how genetic variation in T cells may alter the progression of neurodegeneration.